Ethics and Public Policy Webinars
Outcome/Accomplishment
The NSF-funded Engineering Research Center (NSF ERC) for Advanced Technologies for the Preservation of Biological Systems (NSF ATP-Bio), co-led by the University of Minnesota and the Massachusetts General Hospital, pursues advances in cryopreservation. ATP-Bio’s Ethics & Public Policy (EPP) component hosts two public webinars per year on the Ethical, Legal, and Societal Implications (ELSI) of ATP-Bio’s work. The 2025 EPP webinars presented work published in EPP’s symposium in the Journal of Law, Medicine & Ethics.
Impact/Benefits
These webinars offer ERC and external stakeholders an opportunity to consider the ELSI implications of ATP-Bio technologies
Explanation/Background
In the journal, work presented in the webinars by several ATP-Bio researchers was published. Andrew Maynard, PhD, presented on research with ATP-Bio Partners using a “Risk Innovation” approach designed to help organizations clarify areas of both risk and value. Justyna Jaskiewicz, DMV, PhD, and Rebecca Sandlin, PhD, analyzed the risks and benefits of emerging cryopreservation technologies to biopreserve globally important—but potentially dangerous—pathogens. The published papers that were the basis of these presentations can be accessed at:
Location
Minneapolis, Minnesotawebsite
Start Year
Biotechnology and Healthcare
Biotechnology and Healthcare
Lead Institution
Core Partners
Fact Sheet
Outcome/Accomplishment
The NSF-funded Engineering Research Center (NSF ERC) for Advanced Technologies for the Preservation of Biological Systems (NSF ATP-Bio), co-led by the University of Minnesota and the Massachusetts General Hospital, pursues advances in cryopreservation. ATP-Bio’s Ethics & Public Policy (EPP) component hosts two public webinars per year on the Ethical, Legal, and Societal Implications (ELSI) of ATP-Bio’s work. The 2025 EPP webinars presented work published in EPP’s symposium in the Journal of Law, Medicine & Ethics.
Location
Minneapolis, Minnesotawebsite
Start Year
Biotechnology and Healthcare
Biotechnology and Healthcare
Lead Institution
Core Partners
Fact Sheet
Impact/benefits
These webinars offer ERC and external stakeholders an opportunity to consider the ELSI implications of ATP-Bio technologies
Explanation/Background
In the journal, work presented in the webinars by several ATP-Bio researchers was published. Andrew Maynard, PhD, presented on research with ATP-Bio Partners using a “Risk Innovation” approach designed to help organizations clarify areas of both risk and value. Justyna Jaskiewicz, DMV, PhD, and Rebecca Sandlin, PhD, analyzed the risks and benefits of emerging cryopreservation technologies to biopreserve globally important—but potentially dangerous—pathogens. The published papers that were the basis of these presentations can be accessed at: